26 Stocks Just Hit All-Time Highs on the Same Day: Tickeron AI Says Buy 8, Sell 18
Data as of October 6, 2026 (intraday)
Key Takeaways
- The claim checks out, with one small exception. In our price data, 25 of the 26 stocks traded above their previous record high at some point on October 6. TBBB peaked at $54.34, just 0.37% short of its prior record of $54.54, so its new high is unconfirmed.
- The backdrop: the S&P 500 and Nasdaq touched record highs as Treasury yields retreated from multi-year peaks and oil prices fell (Economic Times).
- Not every record held. Genomics names reversed hard after setting records: TWST fell 24.0% from its intraday high after insider selling GRAL 17.4%, GH 10.6% and NTRA 8.3%.
- Tickeron AI's verdict: 8 BUYS, 18 SELLS. Many of these stocks now trade above the average analyst target. Momentum is real, but the analysts haven't caught up.
- Top BUYS: NVDA (+42.1% to target), APH (+17.2%), GH (+15.4%, after the dip), KEYS (+10.6%) and JCI (+9.3%).
- Tickeron has built Financial Learning Models (FLMs) and AI Trading Bots for all 26 stocks. The FLMs read each stock's trend, including breakouts and failed breakouts, and the Bots weigh sector rotation across chips, cybersecurity, genomics and industrials.
How to Read This Report
- "vs. prior record" compares today's intraday high with the highest price in our data before today. Our history goes back to 2016, or to the IPO for younger companies.
- "Faded" is how far the stock now sits below today's intraday high. A big fade on a record day is a warning sign called a reversal: buyers pushed the stock to a new high and sellers immediately took over.
- "Upside" is the gap to the average analyst price target. A negative number means the stock already trades above what analysts think it's worth.
Group 1: AI Chips and Connectivity Hardware (NVDA, AMD, LITE, APH, HPE, KEYS)
These companies supply the hardware, optics, connectors and test gear behind the AI build-out.
NVDA (Nvidia) — BUY. 1-month forecast: UP. A record high of $243.37 still leaves +42.1% to the $340.00 average target, with 100% of analysts bullish, the biggest cushion in the group.
AMD (AMD) — SELL. 1-month forecast: DOWN. A $1.06T company at a record $658.52, with only +7.3% left to target, is priced for perfection.
LITE (Lumentum) — SELL. 1-month forecast: DOWN. At $1,133.40, with only +3.4% left to target, the optical-networking rally has run ahead of the analysts.
APH (Amphenol) — BUY. 1-month forecast: UP. A connector maker levered to AI data centers set a record high with +17.2% still to target and 86% of analysts bullish.
HPE (Hewlett Packard Enterprise) — SELL. 1-month forecast: DOWN. The record is real, but only +4.4% remains to target, a thin cushion after the breakout.
KEYS (Keysight Technologies) — BUY. 1-month forecast: UP. The test-equipment maker set a record, with +10.6% upside and 89% of analysts bullish.
Group 2: Cybersecurity and Data Infrastructure (CRWD, PANW, FTNT, NET, FFIV, RBRK, P)
Every security name on the list hit a record on the same day, a clear sign of a crowded trade.
CRWD (CrowdStrike) — SELL. 1-month forecast: DOWN. The record of $286.99 is +4.65% above its prior peak, but the stock trades above its $246.22 target (implied upside -11.7%).
PANW (Palo Alto Networks) — SELL. 1-month forecast: DOWN. The biggest breakout in the group, +5.57% above its old record, left the stock above its $402.33 target (implied upside -4.2%).
FTNT (Fortinet) — SELL. 1-month forecast: DOWN. It trades well above its $162.33 target (implied upside -15.1%), and none of the recent analysts are bullish.
NET (Cloudflare) — SELL. 1-month forecast: DOWN. It set a record at $370.35, then faded 4.1% to trade above its target, an early reversal signal.
FFIV (F5) — SELL. 1-month forecast: DOWN. At $469.79, it trades above its $423.00 target (implied upside -10.0%), with analysts split 50/50.
RBRK (Rubrik) — SELL. 1-month forecast: DOWN. 90% of analysts are bullish, but the stock has already passed their $120.40 average target.
P (Everpure) — SELL. 1-month forecast: DOWN. The data-storage record has pushed the stock above its $144.10 target (implied upside -2.1%), so wait for a pullback.
Group 3: Genomics and Life-Science Tools (GH, GRAL, NTRA, TWST, TMO, WAT)
Cancer-detection and lab-tools stocks set records, then several reversed sharply in the same session.
GH (Guardant Health) — BUY. 1-month forecast: UP. After fading 10.6% from its $191.01 record, it offers +15.4% to target with 100% of analysts bullish, the best dip in the group.
GRAL (Grail) — SELL. 1-month forecast: DOWN. A 17.4% fade from its intraday record, ahead of an FDA review of its Galleri test (MarketBeat), leaves the stock above its target and exposed to headline risk.
NTRA (Natera) — SELL. 1-month forecast: DOWN. It faded 8.3% from its record in a profit-taking day (TradingKey), with only +3.5% to target.
TWST (Twist Bioscience) — SELL. 1-month forecast: DOWN. A 24.0% collapse from its record high, with executives selling and the stock already above its $128.43 target, is a classic blow-off top.
TMO (Thermo Fisher) — SELL. 1-month forecast: DOWN. It reversed 5.4% from its record and trades above its $617.14 target (implied upside -6.0%).
WAT (Waters) — BUY. 1-month forecast: UP. It is the only life-science tools name with real room left: +7.1% to target, and 90% of analysts bullish.
Group 4: Real-Economy and Infrastructure (JCI, WCC, ACA, VLO, XMTR)
Data-center cooling, electrical distribution, infrastructure products, refining and manufacturing marketplaces.
JCI (Johnson Controls) — BUY. 1-month forecast: UP. The building-systems and data-center cooling company set a record, with +9.3% still to target.
WCC (Wesco International) — BUY. 1-month forecast: UP. The electrical-distribution supplier to data centers hit a record with +6.4% upside, and every recent analyst is bullish.
ACA (Arcosa) — SELL. 1-month forecast: DOWN. Its record barely cleared the prior peak (+0.15%), and the stock trades above its $132.50 target (implied upside -9.6%).
VLO (Valero Energy) — SELL. 1-month forecast: DOWN. With oil prices falling and the stock already at its $416.33 target (implied upside -0.7%), the refining rally looks tired.
XMTR (Xometry) — SELL. 1-month forecast: DOWN. A strong +4.04% breakout above its old high, but the stock already trades above its $108.43 target.
Group 5: Consumer and Digital-Health Growth (HNGE, TBBB)
HNGE (Hinge Health) — BUY. 1-month forecast: UP. The digital physical-therapy platform has +8.1% to target, with 89% of analysts bullish, at a fresh record.
TBBB (BBB Foods) — SELL. 1-month forecast: DOWN. Today's high fell just short of its prior record, and with only +1.4% to target there is little left to gain.
Scoreboard
|
Ticker |
Group |
Today's high |
Prior record |
vs. prior record |
Price |
Faded |
Avg. target |
Upside |
Call |
|
AI Hardware |
$243.37 |
$240.10 |
+1.36% |
$239.24 |
1.7% |
$340.00 |
+42.1% |
BUY | |
|
AI Hardware |
$658.52 |
$645.46 |
+2.02% |
$649.42 |
1.4% |
$697.00 |
+7.3% |
SELL | |
|
AI Hardware |
$1,137.20 |
$1,124.40 |
+1.14% |
$1,133.40 |
0.3% |
$1,172.00 |
+3.4% |
SELL | |
|
AI Hardware |
$89.93 |
$89.26 |
+0.75% |
$88.62 |
1.5% |
$103.86 |
+17.2% |
BUY | |
|
AI Hardware |
$71.22 |
$70.29 |
+1.32% |
$70.56 |
0.9% |
$73.67 |
+4.4% |
SELL | |
|
AI Hardware |
$389.83 |
$388.75 |
+0.28% |
$387.90 |
0.5% |
$429.00 |
+10.6% |
BUY | |
|
Cyber/Data |
$286.99 |
$274.23 |
+4.65% |
$278.86 |
2.8% |
$246.22 |
-11.7% |
SELL | |
|
Cyber/Data |
$432.32 |
$409.50 |
+5.57% |
$419.91 |
2.9% |
$402.33 |
-4.2% |
SELL | |
|
Cyber/Data |
$192.41 |
$184.63 |
+4.21% |
$191.27 |
0.6% |
$162.33 |
-15.1% |
SELL | |
|
Cyber/Data |
$370.35 |
$367.43 |
+0.79% |
$355.02 |
4.1% |
$346.20 |
-2.5% |
SELL | |
|
Cyber/Data |
$471.80 |
$462.00 |
+2.12% |
$469.79 |
0.4% |
$423.00 |
-10.0% |
SELL | |
|
Cyber/Data |
$127.90 |
$124.27 |
+2.92% |
$125.80 |
1.6% |
$120.40 |
-4.3% |
SELL | |
|
Cyber/Data |
$149.04 |
$144.03 |
+3.48% |
$147.26 |
1.2% |
$144.10 |
-2.1% |
SELL | |
|
Genomics/Tools |
$191.01 |
$187.69 |
+1.77% |
$170.69 |
10.6% |
$197.00 |
+15.4% |
BUY | |
|
Genomics/Tools |
$166.19 |
$156.49 |
+6.20% |
$137.28 |
17.4% |
$127.83 |
-6.9% |
SELL | |
|
Genomics/Tools |
$436.94 |
$427.47 |
+2.22% |
$400.65 |
8.3% |
$414.79 |
+3.5% |
SELL | |
|
Genomics/Tools |
$219.71 |
$214.07 |
+2.64% |
$166.97 |
24.0% |
$128.43 |
-23.1% |
SELL | |
|
Genomics/Tools |
$694.33 |
$683.63 |
+1.56% |
$656.58 |
5.4% |
$617.14 |
-6.0% |
SELL | |
|
Genomics/Tools |
$454.50 |
$448.21 |
+1.40% |
$436.45 |
4.0% |
$467.50 |
+7.1% |
BUY | |
|
Real Economy |
$160.36 |
$157.53 |
+1.83% |
$158.76 |
1.0% |
$173.60 |
+9.3% |
BUY | |
|
Real Economy |
$388.58 |
$385.37 |
+0.83% |
$384.09 |
1.2% |
$408.75 |
+6.4% |
BUY | |
|
Real Economy |
$147.22 |
$147.00 |
+0.15% |
$146.50 |
0.5% |
$132.50 |
-9.6% |
SELL | |
|
Real Economy |
$422.88 |
$421.98 |
+0.21% |
$419.22 |
0.9% |
$416.33 |
-0.7% |
SELL | |
|
Real Economy |
$112.94 |
$108.55 |
+4.04% |
$110.66 |
2.0% |
$108.43 |
-2.0% |
SELL | |
|
Growth |
$100.36 |
$99.81 |
+0.55% |
$98.35 |
2.0% |
$106.33 |
+8.1% |
BUY | |
|
Growth |
$54.34 |
$54.54 |
-0.37% |
$54.24 |
0.2% |
$55.00 |
+1.4% |
SELL |
The pattern: a record high is a momentum signal, not a valuation signal. 13 of these 26 stocks now trade above their average analyst target. The BUYS are the record-setters that analysts still see as undervalued.
How Tickeron's FLMs and AI Trading Bots Handle Record Highs
Tickeron has created a Financial Learning Model (FLM) for every stock in this report: NVDA, AMD, CRWD, NET, PANW, LITE, ACA, APH, FFIV, FTNT, GH, GRAL, HNGE, HPE, JCI, KEYS, NTRA, P, RBRK, TBBB, TMO, TWST, VLO, WAT, WCC and XMTR. Each FLM learns its stock's trend behavior. That is how it separates a genuine breakout that holds (like LITE, trading 0.3% from its high) from a failed breakout that reverses the same day (like TWST and GRAL).
Tickeron also runs AI Trading Bots for all 26. The Bots take the sector into account. When every cybersecurity stock hits a record on the same day, they recognize a crowded sector trade and adjust position sizes, rather than chasing each name on its own.
The bottom line: all-time highs tell you where the momentum is. Analyst targets, intraday reversals and sector crowding tell you whether you are still early. Use the FLMs and Bots to tell the two apart.
For informational purposes only; not investment advice. Prices as of October 6, 2026, intraday. Record-high checks use our daily price history (from 2016, or from each company's IPO for younger names). Average targets reflect the 10 most recent analyst ratings in our data. Tickeron AI forecasts are model-based and do not guarantee future results.
Tickeron AI Perspective
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
TWST in +9.01% Uptrend, growing for three consecutive days on October 05, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where TWST advanced for three days, in 233 of 291 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Aroon Indicator entered an Uptrend today. In 175 of 224 cases where TWST Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
Bearish Trend Analysis
The 10-day RSI Indicator for TWST moved out of overbought territory on October 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 48 similar instances where the indicator moved out of overbought territory. In 41 of the 48 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 53 of 63 cases where TWST's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 84%.
The Momentum Indicator moved below the 0 level on October 07, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TWST as a result. In 67 of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.
The Moving Average Convergence Divergence Histogram (MACD) for TWST turned negative on October 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 41 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TWST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
TWST broke above its upper Bollinger Band on September 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. TWST’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (26.738) is normal, around the industry mean (26.780). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (20.243) is also within normal values, averaging (438.009).
The Tickeron Profit vs. Risk Rating rating for this company is 79 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TWST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a developer of proprietary semiconductor-based synthetic DNA manufacturing process
Industry Biotechnology
Advertisement